 The FDA has approved Allergan and AbbVie Incs NYSE: ABBV BOTOX onabotulinumtoxinA. It is used to treat detrusor bladder muscle overactivity associated with a neurologic condition in pediatric patients five years of age and older who have an inadequate response to or are intolerant of anticholinergic medication. 